Register entry
- Registered sites
- 0
- Active NDC listings
- 18
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
1818 active NDC listings: 18 human prescription drug. By marketing category: NDA 18.
| Dosage form | NDCs |
|---|---|
| injection, solution | 4 |
| capsule | 3 |
| tablet, film coated, extended release | 3 |
| aerosol, metered | 2 |
| granule, delayed release | 2 |
| powder, metered | 2 |
| spray | 1 |
| tablet | 1 |
| Route | NDCs |
|---|---|
| oral | 9 |
| intramuscular | 4 |
| intravenous | 4 |
| respiratory (inhalation) | 4 |
| nasal | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| covis pharma us, inc | 18 |
Catalogue
Marketed products
18| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Alvesco | ciclesonide | aerosol, metered, respiratory (inhalation) | 70515-711NDA |
| Alvesco | ciclesonide | aerosol, metered, respiratory (inhalation) | 70515-712NDA |
| DUAKLIR PRESSAIR | aclidinium bromide and formoterol fumarate | powder, metered, respiratory (inhalation) | 70515-001NDA |
| LANOXIN | digoxin | injection, solution, intramuscular, intravenous | 70515-260NDA |
| LANOXIN | digoxin | injection, solution, intramuscular, intravenous | 70515-261NDA |
| LANOXIN | digoxin | injection, solution, intramuscular, intravenous | 70515-262NDA |
| LANOXIN | digoxin | injection, solution, intramuscular, intravenous | 70515-263NDA |
| Omnaris | ciclesonide | spray, nasal | 70515-701NDA |
| Prilosec | omeprazole magnesium | granule, delayed release, oral | 70515-610NDA |
| Prilosec | omeprazole magnesium | granule, delayed release, oral | 70515-625NDA |
| Sular | nisoldipine | tablet, film coated, extended release, oral | 70515-500NDA |
| Sular | nisoldipine | tablet, film coated, extended release, oral | 70515-501NDA |
| Sular | nisoldipine | tablet, film coated, extended release, oral | 70515-503NDA |
| Tudorza Pressair | aclidinium bromide | powder, metered, respiratory (inhalation) | 70515-002NDA |
| Zanaflex | tizanidine hydrochloride | tablet, oral | 70515-594NDA |
| Zanaflex | tizanidine hydrochloride | capsule, oral | 70515-602NDA |
| Zanaflex | tizanidine hydrochloride | capsule, oral | 70515-604NDA |
| Zanaflex | tizanidine hydrochloride | capsule, oral | 70515-606NDA |
Compare
Other companies listing digoxin
- Aphena Pharma Solutions - Tennessee, LLC0 sites · 795 NDC
- Advanz Pharma (US) Corp.0 sites · 20 NDC
Enquiry
Common questions
- Is Covis Pharma US, Inc FDA approved?
- Covis Pharma US, Inc holds no registered establishment of its own; 18 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Covis Pharma US, Inc make?
- 18 products are listed under Covis Pharma US, Inc in the openFDA NDC Directory, most often as injection, solution; capsule; tablet, film coated, extended release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.